REVIEW AND STUDY OF METAL COMPLEXES WITH ANTIFUNGAL POTENTIAL AGAINST Candida albicans STRAINS
Background: Candidiasis, caused mainly by Candida albicans yeast, is a pathology that affects a significant amount of people in the world, mainly women, thus being a public health issue. In addition, clinical practice has found it difficult to treat candidiasis for two reasons: the multidrug resistance associated with the exacerbated use of available drugs and the high number of side effects caused by current antifungal drugs. In this scenario, this work is a literature review on the antifungal activity of metal complexes against C. albicans since they are extensively studied for their varied applications in health sciences, as an object of study in the area of inorganic chemistry, in the subareas of bioinorganic chemistry and pharmaceutical chemistry. Aim: The present work consists of a literature review in electronic databases on the potential antifungal action against Candida albicans presented by metal complexes. Methods: Data was collected using the Capes, PubMed, Cochrane Reviews and Virtual Health Library (BVS) databases. Results: The results obtained through bibliographic surveys show the importance of studies of metal complexes against the strain of C. albicans, which have promising inhibitory activities and in some cases, with Minimum Inhibitory Concentration (MIC) values lower than 20µg/mL Discussion: The results obtained through bibliographic surveys show the importance of studies of metal complexes against the strain of C. albicans, which have promising inhibitory activities, and in some cases, with Minimum Inhibitory Concentration (MIC) values lower than 20µg/mL. Conclusion: Highlighting the activity performed by ruthenium complexes and Schiff bases when coordinated to metallic ions arouses great interest in a future study of a complex of this metal with a Schiff base in its coordination site.
Read ArticleD-DIMER A RISK FACTOR ASSOCIATED WITH C-REACTIVE PROTEIN FOR PREDICTING THE SEVERITY OF INFECTION BY COVID-19
Background: COVID-19, caused by SARS-CoV-2, has unresolved mortality risk factors and clinical course, highlighting the need for further research. Aims: The study aimed to asses D-dimer and C-Reactive Protein (CRP) as the risk factors for severity covid-19 and who are less capable of surviving. Methods: A retrospective study conduct of COVID-19 in adult inpatients aged >20 at Al-sadder and Alamal Hospital in Iraq. Demographics, clinical trials, treatments, and viral RNA samples were analyzed. The study involved 100 patients, with 67 discharged and 33 hospitalized died. The majority of the participants 45% were aged < 40, but 55% were aged >40 years. Results: A significant and 57% were male 37(55.2%) Survivor vs. 20 (60.6%) non-survivor, p=0.024), more than 43% were female (30(44.8%) Survivor vs. 13(39.4%) non-survivor, p=0.010. Patients had underlying comorbidities (66%), survivor 37(55%), and non-survivor 29(87%). The most prominent comorbidity in non-survivors more than survivors was diabetic mellitus 85%, asthma 58%, stroke 48%, renal failure 42%, heart strake 33%, and hypertension 18%. The study found significant differences in WBC, lymphocyte count, D-dimer, Ferritin, CRP, and LDH levels in non-survivors compared to survivor patients, with a positive correlation between D- dimer and these parameters. The ROC analysis curve showed CRP with a high AUC of 80.2%, 87.9% sensitivity, and 37.3% specificity, while D-dimer and LDH had AUCs of 0.74.9 and 70%, respectively. Discussion: The study found that older age, higher d-dimer, ferritin, CRP, and LDH are associated with disease severity and higher mortality risk in adult COVID-19 patients. Conclusions: These biomarkers could aid in early detection of disease progression signs and better patient management
Read ArticleHIGH BURDEN OF VITAMIN D DEFICIENCY AND FERRITIN-LINKED IMPACT IN Β-THALASSEMIA MAJOR
Background: Background: Vitamin D plays an essential role in bone health and overall physiological function, and its deficiency is common in children and adolescents with β-thalassemia major (βTM). Iron overload, as reflected by elevated ferritin, may further influence vitamin D status. Aim: This study aimed to evaluate serum vitamin D levels in βTM patients and determine their association with ferritin levels. Methods: A total of 40 βTM patients and 20 age-matched healthy controls (aged 4–25 years) were enrolled between October 2024 and February 2025. Serum vitamin D, calcium, ferritin, and hemoglobin were measured. Statistical analysis, including correlation and logistic regression, was performed using SPSS v.26 to identify predictors of vitamin D deficiency. Results: Vitamin D deficiency was highly prevalent among βTM patients (70%) compared with controls. Patients showed significantly lower vitamin D levels (17.32±1.56) than controls (25.34±1.76). Vitamin D levels were positively correlated with age (r = 0.788), calcium (r = 0.772), and hemoglobin (r = 0.771), and negatively correlated with ferritin (r = −0.517). Logistic regression demonstrated that ferritin >1000 ng/mL strongly predicted vitamin D deficiency (OR = 17.875; 95% CI: 3.258–98.074; p = 0.001), while younger age ( < 10 years) also increased the odds of deficiency (OR = 5.200; p = 0.018). Discussion: D deficiency is a prevalent and intrinsic metabolic disturbance in β-thalassemia major, closely linked to chronic iron overload and elevated ferritin levels. This interplay disrupts hepatic vitamin D hydroxylation, induces inflammation, and contributes to endocrine and skeletal complications, highlighting ferritin as a key predictor of deficiency in these patients. Conclusion: Vitamin D deficiency is highly prevalent in βTM and is strongly associated with elevated ferritin levels, suggesting that iron overload is a significant predictor. Integrating vitamin D assessment into routine monitoring may support better management of disease-related metabolic disturbances in patients with βTM.
Read Article